Vascular Solutions Director Sells $39,400 in Stock (VASC)
Vascular Solutions (NASDAQ:VASC) Director Jorge Saucedo unloaded 2,000 shares of the stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $19.70, for a total transaction of $39,400.00. Following the completion of the sale, the director now directly owns 16,687 shares in the company, valued at approximately $328,734. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Canaccord Genuity raised their price target on shares of Vascular Solutions from $21.00 to $22.50 in a research note to investors on Wednesday, October 23rd. They now have a “buy” rating on the stock. Analysts at Feltl & Co. raised their price target on shares of Vascular Solutions from $18.75 to $21.00 in a research note to investors on Wednesday, October 23rd. They now have a “buy” rating on the stock. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $19.83.
Shares of Vascular Solutions (NASDAQ:VASC) traded down 1.41% during mid-day trading on Tuesday, hitting $19.55. 63,373 shares of the company’s stock traded hands. Vascular Solutions has a one year low of $12.98 and a one year high of $17.37. The stock’s 50-day moving average is $16.30 and its 200-day moving average is $15.75. The company has a market cap of $329.1 million and a price-to-earnings ratio of 31.53.
Vascular Solutions (NASDAQ:VASC) last announced its earnings results on Tuesday, October 22nd. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.12. The company had revenue of $28.01 million for the quarter, compared to the consensus estimate of $27.10 million. During the same quarter in the previous year, the company posted $0.16 earnings per share. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. Analysts expect that Vascular Solutions will post $0.70 EPS for the current fiscal year.
Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.